ENTA
EnantaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade C from latest DB weights. Momentum 59.2 / Value 41.1
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -11.1.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
59
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $18.50
Why
Momentum59 · Δ7d -11.1
Value41 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
59
52% active weight
Current posture
7d trendSoftening
Δ7d
-11.1
Δ21d
-9.0
Value
41
48% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 59.2 / Value 41.1
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$368.42M
Beta
0.99
Shares Out
28.86M
P/E (TTM) · Derived
-3.3
P/S (TTM)
6.15
P/FCF (TTM) · Derived
-8.47
Rev YoY
+3.5%
EPS YoY
+35.7%
Gross Margin
-
Op Margin
-130.7%
Net Debt
-$45.71M
Current Ratio
4.21
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology